Wet Wrapping Efficacy.

Atopic eczema (also known as atopic dermatitis) is a common condition, especially in children, ranging from mild flexural involvement to severe and chronic inflammatory disease that can persist for years. Most children will outgrow their eczema but for some it can persist into adulthood.

Wet wrapping is a technique used in the treatment of atopic eczema when the condition has not responded to the first-line management of emollients and topical corticosteroids. It consists of a layer of warm, wet Tubifast 2-Way Stretch bandage or Garment covered by a corresponding layer of dry Tubifast 2-Way Stretch bandage or Garment. Emollients, with or without topical corticosteroids, are applied before the bandaging is put in place. The wet wrap technique is aimed at rehydrating and cooling the skin and reducing inflammation through increased absorption of topical corticosteroids which in turn reduces the itch-scratch cycle (1).

Clinical research reported on the successful use of emollient-antiseptic preparations with wet wrap dressings on six subjects (three children and three adults) with acute exacerbated atopic eczema. The most pronounced changes reported were for itch and sleep loss. The improvement in the condition of the skin lasted beyond the actual treatment period. A reduction in Staphylococcus aureus colonisation was also noted (2).







In a study that treated 12 children (mean 8.5 years; range 3-12 years) with severe atopic eczema who had failed to respond to conventional topical corticosteroid and emollient therapy with a 2-week course of once-daily diluted 0.1% mometasone furoate wet-wraps. A significant improvement, as shown by a marked reduction in clinical severity scores, (measuring the severity of clinical lesions) and self-assessment scores (measuring the severity of the symptoms as reported by the patients/parents) was seen in 11 patients and overall mean scores were significantly improved (p < 0.005). The adverse effects were described by the authors as mild, tolerable and self-limiting, and post-treatment early morning plasma cortisol levels were not depressed (3).

Authors investigated the effectiveness and hypothalamic-pituitary-adrenal (HPA) axis suppression of various corticosteroid dilutions in children with severe atopic dermatitis using wet wrap dressings. Eighteen subjects were treated with a 50% dilution of fluticasone propionate 0.05% cream for 2 weeks. In another five subjects, a side-to-side comparison was carried out with 10%, 25% and 50% dilutions of fluticasone propionate cream under wet wrap dressings. A further eight subjects were treated with 0% (emollient only), 5%, 10% or 25% dilutions of fluticasone propionate cream applied to the whole body under wet wrap dressings. After one week, a major improvement averaging 74% was noted in regard to SCORAD rating (severity scoring of atopic dermatitis). No apparent differences between 5%, 10% or 25% dilutions of the corticosteroid were observed. Of the three groups of subjects included in the study, HPA axis suppression was noted in only 3 of 23 subjects, in the first and second groups.(4).

The use of wet wrap dressings in the management of atopic eczema in both children and adults is reviewed in numerous published articles: these are listed below.

REFERENCES

  • 1

    Twitchen LJ, Lowe AJG Atopic Eczema and Wet-Wrap Dressings Professional Nurse 1998; 14 (2): 113-6

  • 2

    Abeck D, Brockow K, Mempel M, et al Treatment of Acute Exacerbated Atopic Eczema with Emollient-antiseptic Preparations Using the ‘Wet-wrap’ (‘wet pyjama’) Technique. Hautarzt 1999; 50 (6): 418-21

  • 3

    Tang WYM, Chan HHL, Lam VMF et al Outpatient, Short-term, Once-daily, Diluted, 0.1% Mometasone Furoate Wet-wraps for Childhood Atopic Eczema. Journal of Dermatological Treatment 1999; 10 (3): 157-63

  • 4

    Wolkerstorfer A, Visser RL, de Waard-Van Der Spek FB et al Efficacy and Safety of Wet-wrap Dressings in Children with Severe Atopic Dermatitis: Influence of Corticosteroid Dilution. British Journal of Dermatology 2000; 143: 999-1004

FURTHER READING

  • Atherton D Treatment Choices in the Management of Eczema. Prescriber 1994; March 5: 3-8

  • Bridgman A Management of Atopic Eczema in the Community Health Visitor 1994; 67 (7): 226-7

  • Bridgman A The Use of Wet Wrap Dressings for Eczema. Paediatric Nursing 1995; 7 (2): 24-7

  • Bridgman A It’s a Wrap. The Independent Community Pharmacist 1997; March: 32-3

  • Donald S Atopic Eczema: Management and Control. Paediatric Nursing 1995; 7 (2): 29-35

  • Lambert A The Role of Wet-wrapping Technique in Eczema Management. Community Nurse Supplement 1998; October Supplement: 53-4

  • Mallon E, Powell S, Bridgman A Wet-wrap Dressings for the Treatment of Atopic Eczema in the Community. Journal of Dermatological Treatment 1994; 5: 97-8

  • Oranje AP, Wolkerstorfer A, de Waard-Van Der Spek FB Treatment of Erythrodermic Atopic Dermatitis with ‘Wet-wrap’ Fluticasone Propionate 0.05% Cream/Emollient 1: 1 Dressings. Journal of Dermatological Treatment 1999; 10 (1): 73-4

  • Stapleton M Eczema: Clinical Presentation and Management. Pharmacy Magazine 1999; January (Suppl): I-VII

  • Venables J Management of Children with Atopic Eczema in the Community. Dermatology in Practice 1995; September/October: 51-4

  • Venables J The Management and Treatment of Eczema. Nursing Standard 1995; 9 (14): 25-8

  • Venables J Bandaging and Wet-wraps. Exchange: Journal of the National Eczema Society 1999; December: 30-1